drugset / Trial / NCT06360796
Study of Pharmacokinetics and Metabolism on [(14)C]ADC189
NaSingle-groupOpen-labelBasic science
Summary
This study is designed to determined the metabolism, excretion, and substance balance of almonertinib of ADC189. The pharmacokinetic characteristics and safety profile of ADC189 was investigated following a single oral dose (45 mg/100 µCi) in healthy Chinese male participants.
Timeline
- Start
- 2023-11-24
- Primary completion
- 2024-02-20
- Completion
- 2024-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADC189 | Unknown | 45 mg | Oral |
Indications
No indication recorded.